How were Diplomat Pharmacy's earnings last quarter?
Diplomat Pharmacy Inc (NYSE:DPLO) announced its earnings results on Tuesday, November, 12th. The company reported ($2.35) earnings per share for th...
Who are Diplomat Pharmacy's key executives?
Diplomat Pharmacy's management team includes the following people: Mr. Brian Thomas Griffin , CEO & Chairman (Age 60) Mr. Philip R. Hagerman ,...
Who are some of Diplomat Pharmacy's key competitors?
Some companies that are related to Diplomat Pharmacy include PetMed Express (PETS) , Rite Aid (RAD) , 111 (YI) , MedAvail (MDVL) , Progressive...
What other stocks do shareholders of Diplomat Pharmacy own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Diplomat Pharmacy investors own include Bausch Health Comp...
What is Diplomat Pharmacy's stock symbol?
Diplomat Pharmacy trades on the New York Stock Exchange (NYSE) under the ticker symbol "DPLO."
What is Diplomat Pharmacy's stock price today?
One share of DPLO stock can currently be purchased for approximately $4.00.
How much money does Diplomat Pharmacy make?
Diplomat Pharmacy has a market capitalization of $304 million and generates $5.49 billion in revenue each year. The company earns $-302.27 million...
How many employees does Diplomat Pharmacy have?
Diplomat Pharmacy employs 2,335 workers across the globe.
What is Diplomat Pharmacy's official website?
The official website for Diplomat Pharmacy is www.diplomatpharmacy.com .
About DPLO
Diplomat is a nationally recognized specialty pharmacy, and here, we offer a special kind of care. At Diplomat, we blend clinical excellence with a personal touch, providing medications and support to people with serious long-term diseases, including cancer, multiple sclerosis, HIV and rheumatoid arthritis.
Rating
What analysts on recommend for this stock, on a scale from 1 (buy) to 5 (sell).
AppLovin Grows With Synergy, Stock Still Lags in Price
Newly public marketing and mobile app provider posts strong revenue growth but stock stalls.
NFTs Are a New Investing Frontier
The latest alternative investment markets require close attention as action can be fast and furious.
Cramer: Weak Consumer Spending Raises Red Flags
The economic slowdown caused by the delta variant is going to delay the economic recovery.
Targeting Buys and Avoiding Potholes: a Stock Market Guide
There's an art to averaging into an investing position, James 'Rev Shark' Deporre argues.
Biden Outlines Sweeping Steps to Boost Vaccinations
President moves to force all employers with more than 100 employees to require vaccines or weekly negative tests.
Delta's Health Insurance Surcharge Seems to Spark Vaccinations
Two weeks ago, Delta said it would impose a $200 monthly health insurance surcharge on employees who refused to get the vaccine.
GM Will Extend Shutdown at Plant Producing Bolt EVs
GM extended a plant shutdown after a recall of nearly 141,000 Chevrolet Bolts, due to a battery defect that created a fire risk.
